Clerkenwell Health to Provide Clinical Research Support to Drug Developers • Proactive Investors

Press Coverage
Written By Clerkenwell Press Office

Clerkenwell Health's Tom McDonald talks to Proactive London's Katie Pilbeam about their innovative mental health company which offers clinical research support services and psychedelic-assisted therapies.

McDonald says the firm can help to 'accelerate the industry' by providing independent psychedelic-specialist CRO services for adoption of these treatments across Europe.

Clerkenwell Press Office
Previous

Meet Our Leadership Team • Clerkenwell Health
Next

Putting patients at the centre • The New Statesman